Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors by unknown
T
NF-a, also called cachectin, is a protein produced mainly
by macrophages (1) . Besides its antitumor activities, TNF-a
has a multitude ofbiologic and immunologic functions (2-5) .
Recent studies showed the existence of at least two distinct
cell surface receptors for human TNF-a (6) . The same inves-
tigators raisedmAbs against TNF-binding proteins from HL60
and U937 cells, designated Htr and Utr mAbs, respectively
(7) . Studies ofthese mAbs showed that Htr-5 and Htr-9 recog-
nize a TNF-binding protein of -55 W, whereas Utr-1
specifically interacts with a protein of-75 kD molecular mass
(7) . More recently, both human TNF receptors have been
cloned and expressed, and wereshown to have binding prop-
erties similar to their native counterparts (8-10) . The exis-
tence of two antigenically distinct TNF-binding proteins
points to possible differences in signal transduction after TNF
interaction with each ofthese receptors. Accordingly, we ex-
tend our previous- studies (11) in order to examine the ability
of Htr-5 and Utr-1 to influence TNF-a interaction and the
ensuing biologic effects on U937 and endothelial cells.
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Summary
The present study was undertaken to further characterize the interaction ofmonoclonal antibodies
(mAbs) against tumor necrosis factor (TNF) receptors with different targets, and to assess their
ability to influence TNF effects on U937 andhuman endothelial cell (HEC) functions. Actions
of recombinant TNF-a on U937 and HEC were effectively inhibited by Htr-5 and Utr-1, and
to a greater extent by a combination ofboth mAbs. These observations indicate that TNF interaction
with antigenically different components ofmembrane receptors (p55 and p75) represents a crucial
step in transduction of signals forTNF toxicity against U937 andTNF activation ofHEC functions.
Cytokines andmAbs.
￿
The rTNF-a (1) used in this study (Genen-
tech, Inc., San Francisco, CA) was >98% pure and had a specific
activity of 4.8 x 101 U/mg rTNF-a, as determined in a standard
cytotoxicity bioassay (12) . The generation ofmAbs Htr-5, Htr-9,
and Utr-1 against human TNF receptors from HL60 and U937
cells has been reported (6, 7) . Biotinylation ofmAb and rTNF-a
was performed as described (13) .
Cells .
￿
U937 and BL60 cells were obtained from American Type
Culture Collection, Rockville, MD. Human endothelial cells (HEC)
were obtained by collagenase treatment ofhuman umbilical cord
veins and seeded at uniform density (1.5 x 105/well) in 24-well
plates as detailed previously (14, 15).
Flow Cytometric Analysis ofTNFReceptor mAbs Binding .
￿
Ali-
quots of 106 cells were mixed with biotinylated (B) mAb (10 fcg/
ml) and streptavidin PE, and analyzed by FACS essentially as de-
scribed (11). Experiments involving theblocking ofBmAb binding
were performed by pretreating the cells with rTNF-a (50,ug/ml)
for 45 min before addition of the biotinylated reagents .
Cytotoxicity Assay.
￿
100 ul of "Cr-labeled U937 cells were
seeded in each well ofFB microtiter plates (Costar, Cambridge,
MA) together with 100 141 of complete medium containing var-
ious concentrations of rTNF-a with or without mAbs to TNF
receptors (10 tag/ml). After 20 h ofincubation, supernatants were
collected, and their radioactivity was determined . Percent cytotox-
icity expressed as specific lysis was calculated as follows : percent
specific lysis = 100x (A - B)/(C - B) ; whereA represents the
mean cpm in test supernatants, B represents the mean cpm in su-
pernatants of targets alone (spontaneous
51Cr release), and C
represents the mean cpm in supernatants oftargets lysed with 0.25%
SDS (maximum "Cr release) .
HEC Assays.
￿
TNF receptor mAbs or rTNF-a were used for
activation of confluent HEC monolayers for 11,6 production and
for adhesion of "Cr-HL60 cells essentially as described previously
(11, 15). Briefdescriptions ofthese procedures are given below (see
Tables 1 and 2) .
Results
BindingofTNFReceptormAbs to U937 Cells.
￿
The binding
of BUtr-1 and BHtr-9 to cells was examined in a series of
experiments . Representative results in Fig. 1 show that the
two mAbs bound to U937, indicating that these cells ex-
press both Htr and Utr types of TNF receptors, though to
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Figure 1.
￿
Binding of Utr-1 and
Htr-9 to U937. Flow cytometric
analysis of U937 stained with
BUtr-1 or BHtr-9 (10 kg/ml) .
The dottedcurves represent histo-
grams obtainedby analysis of cells
pretreated with rTNF-a (50 hg/
ml) before staining with respec-
FLUORESCENCE
￿
tive antibody.
different extents . Compared with BHtr-9, more pronounced
bindingof BUtr-1 toU937 was evident, as reflectedby greater
fluorescence intensity (Fig . 1) . Thedata also show that U937
pretreated with rTNF for45mincompletely lacked the ability
to bind to BUtr-1 or BHtr-9 . The resultsof additional binding
experiments (not shown) demonstrated that pretreatment of
U937 cellswith Htr-9 resulted in a slight reductionofBrTNF
binding, whereas Utr-1 caused an almost complete inhibi-
tion ofBrTNFbinding, indicating that Utr-1 canoccupy (and
block) apredominant structure that is involved in the inter-
action ofTNF with U937 . These data are consistent with
results published by Brockhaus et al . (7), and indicate the
heterogenous nature of membranal structures involved inTNF
interaction with U937 .
Inhibition ofTNF-a Cytotoxicity on U937 by TNFReceptor
mAbs. Based on the results presented in Fig . 1, it was of
interest to examine whethermAb Utr-1 could influence the
Cytotoxicity induced by TNF on U937 . The results (Fig. 2)
show that Utr-1 is just as effective as Htr-5 in causing
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Figure 2 .
￿
Inhibition ofrTNF-a Cytotoxicity by Utr-1 and Htr-5 . 5 1Cr-
U937 wereincubated in the absence orpresence ofvarious concentrations
of rTNF-a (") with or without the addition of Utr-1 (O), Htr-5 (A),
or both (A). After 20 h, specific cell lysis was determined based on the
amount ofradioactivityreleased in the supernatant, as detailed in Materials
and Methods .
Table 1 .
￿
The influence ofTNF Receptors mAbs on rTNF-a
Stimulation of IL-6 Production from HEC
Cultures ofconfluent HEC monolayers were incubated in duplicate with
and without the addition of various agents as indicated . IL-6 activity in
24-h supernatants was measured, and the data are presented as the mean
of triplicate IL-6 determinations; SD 4 10% . Stimulation index is cal-
culated by dividing IL-6 values from test cultures by IL-6 value in con-
trol cultures .
Table 2.
￿
Regulation of Tumor Cell Adherence to Endothelial
Cells by TNF Receptors mAbs
Treatment of HEC cultures
Properties of Monoclonal Antibodies to Tumor Necrosis Factor Receptors
Percent adherence of HL60
Cultures of confluent HEC monolayers were incubated in the absence
or presence of various agents as indicated. After 4 h, the cultures were
washed twice with HBSS, and each culture received 0.5 x 105 51Cr-HL60
in 0.25 ml medium andwas further incubated for 1 h . Nonadherent cells
were aspirated, the cultures were washed, and adherent 51Cr-HL60were
lysed for determination of retained radioactivity . Each treatment was
performed in duplicate, and the mean cpm from four lysate aliquots
counted is expressed as a percentage of the mean maximum cpm .
None 16
rTNF-a (1 U/ml) 45
Htr-9 (1 ug/ml) 36
Htr-5 (2 jig/ml) 18
Utr-1 (2 p.g/ml) 17
rTNF-ac (1 U/ml) 38
+ Htr-5 (2 ug/ml)
rTNF-ac (1 U/ml) 24
+ Utr-1 (2 ug/ml)
rTNF-a (1 U/ml) 16
+ both mAbs
Htr-9 + Htr-5 14
Htr-9 + Utr-1 37
Htr-9 + both mAbs 16
Agent(s) added
to HEC culture IL-6
Stimulation
index
pg1ml
None 275 1.0
Htr-5 (2.5 t~g/ml) 425 1 .54
Utr-1 (2.5 )Ag/ml) 333 1.21
Both mAbs 333 1.21
rTNF-a (10 U/ml) 1,162 4.22
rTNF-a + Htr-5 691 2.50
rTNF-a + Utr-1 675 2.45
rTNF-a + both mAbs 408 1.48significant inhibition ofTNF cytotoxicity, and that greater
inhibition can be obtained by a combination of both mAbs.
Regulation ofTNF-a Actions on Endothelial Cells by TNF
Receptor mAbs . A series of experiments was performed to
examine whether Utr-1 alone and in combination with Htr-5
can regulate the effects ofTNF-a on HEC functions. Con-
sistent with data reported recently (15), the results in Table
1 show that rTNF-a caused a significant stimulation of IIT6
production after 24 h of incubation . rTNF-a stimulation of
IIr6 production was reduced substantially in the presence of
Htr-5 or Utr-1, and to a greater extent when both mAbs
were added to the cultures. Furthermore, the ability of Htr-5
and Utr-1 to affect rTNF-cr-induced adhesiveness ofHEC was
tested in an adhesion assay using S1Cr-HL60, and the results
are presented in Table 2 . Monolayers ofHEC treated with
1 U/ml of rTNF-a or 1 Irg/ml of Htr-9 (which is known
to mimic TNF-a effect in this system [11]) showed an in-
creased adhesiveness amounting to two- to threefold greater
than control value, as reflected by the adherence of stCr-
HL60 . Htr-5 or Utr-1 by themselves did not increase HEC
adhesiveness. However, the presence ofeither Htr-5 or Utr-1
partially reduced rTNF-a effects, and the presence of both
mAbs inhibited completely the effects ofrTNF-a to control
level . These results indicate that HEC express both Htr and
Utr types ofTNF receptors. Further, while Htr-5 completely
blocked Htr-9 effects (Table 2), the presence of Utr-1 did not
interfere with Htr-9-induced adhesiveness, indicating the lack
of crossreactivity between Utr-1 and Htr-9 .
Discussion
In the present study, we examined further the nature of
TNF interaction with U937 and HEC, and the ensuing bio-
logic response in the presence of mAbs, particularly Utr-1,
which has been shown to recognize a TNF-binding protein
ofN75 kD (p75) in myeloid cells (7) . Previously, we showed
that mAb Htr-9 bound to U937 (11), and here we confirm
this result and further demonstrate that biotinylated Utr-1
bound efficiently to U937 . Flow cytometric analysis ofU937
cells stained with BmAbs with and without pretreatment
with TNF indicate that the predominant molecular compo-
nent ofTNF receptors in U937 cells is a molecular structure
with specificity for Utr-1 .
Previously, we demonstrated that the p55 TNF receptor
is involved in mediating TNF actions on U937, HEC, and
fibroblasts (11) . The present study shows that mAbs Htr-5
and Utr-1 can protect U937 cells to an equal extent against
the cytotoxic effects ofTNF, and that greater protection can
be obtained by a combination of both mAbs . These results
indicate that both p55 and p75 molecular components ofthe
TNF receptors are involved in the transduction of signals
leading to the cytotoxic action ofTNF. This explanation is
supported by the fact that Htr-5 and Utr-1 protected U937
against TNF cytotoxicity. It is interesting to note that at 0.01
ng/mlTNF (Fig. 2), either Htr-5 or Utr-1 tested alone com-
pletely blocked the cytotoxic action ofTNF, while at rela-
tively higher concentrations of TNF (0.1 ng/ml), the com-
bination of both mAbs was required. Of relevance to these
results is the observation that the blocking by Utr-1 of the
p75 receptor decreases the affinity of TNF binding to the
p55 receptor onU937 cell surface (Sundan, A ., unpublished
results) . Similar data of decreased TNF affinities to the p55
receptor were also obtained in experiments ofTNF binding
to HL60 in the presence ofUtr-1(Hohmann, P ., manuscript
in preparation) . In the present study, a decrease in the TNF
affinity to one type of receptors, due to the blocking of an-
other receptor by mAb, may explain the complete reversal
of the cytotoxic action noted when low concentrations of
TNF are used (Fig. 2) . Under otherwise similar experimental
conditions, excessTNF (i4, higher concentrations) may com-
pensate for the decrease in the affinity of TNF binding to
its target leading to partial, rather than complete, inhibition
ofTNF action . The observation thatTNF can exert an effect
on U937 at a low concentration of0.01 ng/ml (Fig. 2), which
is equivalent to -0.58 pM, is-of interest . This result sug-
gests that an extremely low occupancy ofboth types ofTNF
receptors may be sufficient to trigger intracellular events . Fur-
thermore, both Htr-5 and Utr-1 antibodies inhibited TNF
stimulation ofI1r6 production byHEC, and together caused
a complete inhibition of TNF-induced adhesiveness ofHEC
monolayers . It is tempting to suggest that the activation of
endothelial cells by TNF is also mediated by TNF interac-
tion with both the Htr (p55) and the Utr (p75) types of
TNF receptors . The importance of this observation is fur-
ther emphasized in light of the fact that the inflammatory
nature ofTNF is in part due to its ability to influence en-
dothelial cell functions (4, 5) . In this regard, mAbs Htr-5
and Utr-1may have a potential use as antiinflammatory agents
by virtue of their abilities to suppress TNF-associated en-
dothelial activation .
Collectively, the data in this report demonstrate that TNF
interaction with both Htr (p55) and Utr (p75) types of
receptors can trigger cytotoxic- (U937) as well as cell func-
tion-enhancing effects (HEC) . Signals responsible for induc-
tion of different TNF actions may therefore be conveyed via
distinct post-receptor pathways .
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